These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 39270064)

  • 1. Targeting senescence-associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes.
    Xiong J; Dong L; Lv Q; Yin Y; Zhao J; Ke Y; Wang S; Zhang W; Wu M
    Clin Transl Med; 2024 Sep; 14(9):e1772. PubMed ID: 39270064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular senescence and the tumour microenvironment.
    Takasugi M; Yoshida Y; Ohtani N
    Mol Oncol; 2022 Sep; 16(18):3333-3351. PubMed ID: 35674109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of senescence on the tumour microenvironment and response to therapy.
    Reynolds LE; Maallin S; Haston S; Martinez-Barbera JP; Hodivala-Dilke KM; Pedrosa AR
    FEBS J; 2024 Jun; 291(11):2306-2319. PubMed ID: 37873605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
    Chambers CR; Ritchie S; Pereira BA; Timpson P
    Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.
    Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M
    Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cellular senescence and SASP in tumour microenvironment.
    Takasugi M; Yoshida Y; Hara E; Ohtani N
    FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy.
    Jiang B; Zhang W; Zhang X; Sun Y
    Semin Cancer Biol; 2024 Jun; 101():58-73. PubMed ID: 38810814
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Samakkarnthai P; Saul D; Zhang L; Aversa Z; Doolittle ML; Sfeir JG; Kaur J; Atkinson EJ; Edwards JR; Russell GG; Pignolo RJ; Kirkland JL; Tchkonia T; Niedernhofer LJ; Monroe DG; Lebrasseur NK; Farr JN; Robbins PD; Khosla S
    Aging (Albany NY); 2023 May; 15(9):3331-3355. PubMed ID: 37154858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies.
    D'Ambrosio M; Gil J
    Dev Cell; 2023 Jun; 58(12):1007-1021. PubMed ID: 37339603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophages and tumor-associated macrophages in the senescent microenvironment: From immunosuppressive TME to targeted tumor therapy.
    Du M; Sun L; Guo J; Lv H
    Pharmacol Res; 2024 Jun; 204():107198. PubMed ID: 38692466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular senescence and SASP in tumor progression and therapeutic opportunities.
    Dong Z; Luo Y; Yuan Z; Tian Y; Jin T; Xu F
    Mol Cancer; 2024 Aug; 23(1):181. PubMed ID: 39217404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
    Malaquin N; Tu V; Rodier F
    Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications.
    Zhao B; Wu B; Feng N; Zhang X; Zhang X; Wei Y; Zhang W
    J Hematol Oncol; 2023 Mar; 16(1):28. PubMed ID: 36945046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Differential Effect of Senolytics on SASP Cytokine Secretion and Regulation of EMT by CAFs.
    Bogdanova DA; Kolosova ED; Pukhalskaia TV; Levchuk KA; Demidov ON; Belotserkovskaya EV
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP).
    Malaquin N; Rodier F
    Methods Cell Biol; 2024; 181():181-195. PubMed ID: 38302239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The implication of ROCK 2 as a potential senotherapeutic target via the suppression of the harmful effects of the SASP: Do senescent cancer cells really engulf the other cells?
    Şimay Demir YD; Özdemir A; Sucularlı C; Benhür E; Ark M
    Cell Signal; 2021 Aug; 84():110007. PubMed ID: 33845155
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Zhang JW; Zhang D; Yin HS; Zhang H; Hong KQ; Yuan JP; Yu BP
    Gut Microbes; 2023; 15(1):2197836. PubMed ID: 37017266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic strategies targeting cellular senescence for cancer and other diseases.
    Wang X; Fukumoto T; Noma KI
    J Biochem; 2024 Apr; 175(5):525-537. PubMed ID: 38366629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact and potential value of immunosenescence on solid gastrointestinal tumors.
    Zhang T; Wen R; Fan H; Yu Y; Jia H; Peng Z; Zhou L; Yu G; Zhang W
    Front Immunol; 2024; 15():1375730. PubMed ID: 39007138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the senescent microenvironment on tumorigenesis: Insights for cancer therapy.
    Zhang W; Zhang K; Shi J; Qiu H; Kan C; Ma Y; Hou N; Han F; Sun X
    Aging Cell; 2024 May; 23(5):e14182. PubMed ID: 38650467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.